Evoke Pharma (EVOK) Misses Q1 EPS by 4c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).

As of March 31, 2016, the Company’s cash and cash equivalents were approximately $6.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MP Materials seen largely insulated after China export-control move